ESTRO 35 Programme book

TUESDAY 3 MAY 2016

will be given. Safety issues will be covered, and major clinical trial successes and challenges will be highlighted. In addition, future opportunities for advances in preclinical and clinical development of combination therapies will be presented.

Chair: H. Lyng (Norway) Co-chair: L. Livi (Italy)

11:00 > Interaction of radiotherapy with molecular targeting agents Speaker: P. Harari (USA) 11:20 > Challenges combining radiotherapy with immunotherapy Speaker: S. Formenti (USA) 11:40 > New strategies to targeting tumour angiogenesis and hypoxia Speaker: O. Chinot (France)

SP-0603

SP-0604

SP-0605

Symposium with Proffered Papers RADIOMICS - THE FUTURE OF RADIOTHERAPY? 11:00 - 12:00 | ISTANBUL Chair: P. Lambin (The Netherlands) Co-chair: G. Mantini (Italy)

11:00 > Imaging-genomics: identifying molecular phenotypes by integrating radiomics and genomics data Speaker: TBC 11:15 > PET/CT heterogeneity quantification through texture analysis: potential role for prognostic and predictive models Speaker: M. Hatt (France)

SP-0606

SP-0607

11:30 > The potential of radiomics for radiotherapy individualisation Speaker: E. Troost (Germany), K. Pilz, S. Löck, S. Leger, C. Richter

SP-0608

11:45 > Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC E.E.C. De Jong (The Netherlands), W. Van Elmpt, L.E.L. Hendriks, R.T.H. Leijenaar, A.M.C. Dingemans, P. Lambin

OC-0609

Symposium RADIOBIOLOGY OF PROTON / CARBON / HEAVY IONS 11:00 - 12:00 | LONDRA

Chair: M. Pruschy (Switzerland) Co-chair: M. Amichetti (Italy)

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

155